P
ProQR Therapeutics NV D
D
PRQR
2.18000
USD
0.05
(2.35%)
مغلق
حجم التداول
6,607
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
229,647,659
الأخبار المقالات
العنوان: ProQR Therapeutics NV
القطاع: Healthcare
الصناعة: Biotechnology
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.